Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T06:09:40.039Z Has data issue: false hasContentIssue false
  • English
  • Français

Epilepsy in the older patient

Part of: Bespoke shallow archive Weizmann

Published online by Cambridge University Press:  01 May 2007

Ann Johnston  and
Phil Smith
Ann Johnston*
Affiliation:
The Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff, UK
Phil Smith
Affiliation:
The Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff, UK
*
Address for correspondence: A Johnston, The Epilepsy Unit, University Hospital of Wales, Heath Park, Cardiff CF14 4XWUK.
Get access Rights & Permissions [Opens in a new window]

Extract

The world population is aging rapidly. The post World War II ‘baby boomers’ have benefited from improved medical science, sanitation, political freedom, and social and economic development, resulting in the knock-on demographic trend of an aging population. From a health-economic perspective, this places increasing demands on society and on health services to meet evolving medical and social needs. By 2025, over 30% of the populations of developed countries will be aged over 60 years (US Bureau of Census 2004).

Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 17 , Issue 2 , May 2007 , pp. 109 - 118
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Leppik, IE. Introduction to the International Geriatric Epilepsy Symposium (IGES). Epilepsy Res 2006; S1–S4.CrossRefGoogle Scholar
2Hauser, WA. Seizure disorders: the changes with age. Epilepsia 1992; 33 (suppl 4): S6–S14.CrossRefGoogle ScholarPubMed
3Cockerell, OC, Eckle, I, Goodridge, DM et al. Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry 1995; 58: 570–76.CrossRefGoogle Scholar
4Hauser, WA, Annegers, JF, Rocca, WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester Minnesota. Mayo Clin Proc 1996; 71: 576–86.CrossRefGoogle ScholarPubMed
5Stephen, LS, Brodie, MJ. Epilepsy in elderly people. Lancet 2000; 355: 1441–46.CrossRefGoogle ScholarPubMed
6Brodie, MJ, Kwan, P. Epilepsy in elderly people. BMJ 2005; 331: 1317–22.CrossRefGoogle ScholarPubMed
7Cloyd, J, Hauser, W, Towne, A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006; 68 (suppl 1): S39–48.CrossRefGoogle ScholarPubMed
8Forsgren, L, Bucht, G, Eriksson, S, Bergmark, L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 1996; 37: 224–29.CrossRefGoogle ScholarPubMed
9Hauser, WA, Annegers, JF, Kurland, LT. Incidence of epilepsy and unprovoked seizures in Rochester Minnesota: 1935–1984. Epilepsia 1993; 34: 453–68.CrossRefGoogle ScholarPubMed
10Hauser, WA, Annegers, JF, Kurland, LT. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia 1991; 32: 429–45.CrossRefGoogle ScholarPubMed
11Schachter, SC, Crammer, WG, Thompson, GD et al. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatric Soc 1998; 46, 1137–41.CrossRefGoogle ScholarPubMed
12Hopkins, A, Garman, A, Clarke, C. The first seizure in adult life: value of clinical features, electroencephalography and computerised scanning in prediction of seizure recurrence. Lancet 1998; 331: 721–26.CrossRefGoogle Scholar
13Sander, JW, Hart, YM, Johnson, AL, Shorvon, SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990; 336 (8726): 1267–71.CrossRefGoogle ScholarPubMed
14Cleary, P, Shorvon, S, Tallis, R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363: 1184–86.CrossRefGoogle ScholarPubMed
15Hesdorffer, DC, Hauser, WA, Annegers, JF et al. Neurology 1996; 46: 727–30.CrossRefGoogle Scholar
16Ramsay, RE, Rowan, AJ, Pryor, FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62 (suppl 2): S24–29.CrossRefGoogle ScholarPubMed
17Sheth, RD, Drazkowski, JF, Sirven, JI, Gidal, BE, Hermann, BP. Protracted ictal confusion in elderly patients. Arch Neurol 2006; 63: 529–32.CrossRefGoogle ScholarPubMed
18Bottaro, FJ, Martinex, OA, Pardal, MM, Bruetman, JE, Reisin, RC. Nonconvulsive status epilepticus in the elderly: a case-control study. Epilepsia 2007; 5: 966–72.CrossRefGoogle Scholar
19Van Cott, AC. Epilepsy and the EEG in the elderly. Epilepsia 2002; 43 (suppl 3): 94–102.CrossRefGoogle ScholarPubMed
20Sheorajpabday, RVA, De Deyn, PP. Epileptic fits and epilepsy in the elderly: general reflections, specific issues and therapeutic implications. Clin Neurol Neurosurg 2007 (in press).CrossRefGoogle Scholar
21Leppik, IE, Brodie, MJ, Saetre, ER et al. Outcomes research: clinical trials in the elderly. Epilepsy Res 2006 (suppl 68): S71–76.CrossRefGoogle Scholar
22Marson, A, Jacoby, A, Johnson, A et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 365: 2007–13.CrossRefGoogle ScholarPubMed
23Cleary, P, Shorvon, S, Tallis, R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363: 1184–86.CrossRefGoogle ScholarPubMed
24Perucca, E, Berlowitz, D, Birnbaum, A et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006(suppl 68S);S49–S63.CrossRefGoogle Scholar
25Perucca, E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006; 45: 351–63.CrossRefGoogle ScholarPubMed
26Bernus, I, Dickinson, RG, Hooper, WD, Eadie, MJ. Anticonvulsant therapy in aged patients. Clinical pharmacokinetic considerations. Drugs Aging 1997; 10: 278–89.CrossRefGoogle ScholarPubMed
27Leppik, IE, Kelly, KM, deToledo-Morrell, L et al. Basic research in epilepsy and aging. Epilepsy Res 2006 (suppl 68S): S21–S37.CrossRefGoogle Scholar
28Gidal, BE. Drug absorption in the elderly: Biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res 2006 (suppl 68S): S65–S69.CrossRefGoogle Scholar
29Marson, AG, Al-Kharusi, AM, Alwaidh, M et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000–15.CrossRefGoogle ScholarPubMed
30Gillham, R, Bryant-Comstock, L, Kane, K. Validation of the side-effect and life-satisfaction (SEALS) inventory. Seizure 2000; 9: 458–63.CrossRefGoogle ScholarPubMed
31Brodie, MJ, Overstall, PW, Giorgi, L. The UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81–87.CrossRefGoogle Scholar
32Marson, AG, Al-Kharusi, AM, Alwaidh, M et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016–26.CrossRefGoogle ScholarPubMed
33Garrard, J, Harms, S, Hardie, N et al. Antiepileptic drug use in nursing home admissions. Ann Neurol 2003; 54: 75–85.CrossRefGoogle ScholarPubMed
34Huying, F, Klimpe, S, Werhahn, K. Antiepileptic drug use in nursing home residents: a cross-sectional, regional study. Seizure 2006; 15: 194–97.CrossRefGoogle ScholarPubMed
35Birnbaum, AK, Hardie, NA, Conway, JM et al. Phenytoin use in elderly nursing home residents. Am J Pharmacother 2003; 1: 90–95.Google ScholarPubMed
36Birnbaum, AK, Hardie, NA, Leppik, IE et al. Variability of multiple total phenytoin serum concentrations in elderly nursing home residents. Neurology 2003; 60: 555–59.CrossRefGoogle ScholarPubMed
37Schachter, SC, Cramer, GW, Thompson, GD, Chaponis, RJ, Zmendelson, MA, Lawhorne, L. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr. Soc 1998; 46: 1137–1141.CrossRefGoogle ScholarPubMed
38Mohanraj, R, Brodie, MJ. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 2006; 13: 277–82.CrossRefGoogle ScholarPubMed
39Gallo, BV. Epilepsy, surgery and the elderly. Epilepsy Res 2006; (suppl 68S): S83–S86.CrossRefGoogle Scholar
40Beghi, E, Tomini, C. Surgery for epilepsy: assessing evidence from observational studies. Epilepsy Res 2006; 70: 97–102.CrossRefGoogle ScholarPubMed
41Boon, P, Vonck, K, De, RJ, Caemaert, J. Vagus nerve stimulation for refractory epilepsy. Seizure 2002; 11 (suppl A): 448–55.Google ScholarPubMed
42Treiman, DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995; 12: 343–62.CrossRefGoogle ScholarPubMed
43Farhat, G, Yamout, B, Mikati, MA et al. Effect of antiepileptic drugs on bone mineral density in ambulatory patients. Neurology 2002; 58: 1348–53.CrossRefGoogle Scholar
44Ensrud, KE, Walczak, TS, Blackwell, T, Ensrud, ER, Bowman, PJ, Stone, KL. Antiepileptic drug-use increases rates of bone loss in older women: a prospective study. Neurology 2004; 62: 2051–57.CrossRefGoogle ScholarPubMed
45Drezner, MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 2004; suppl 2: S41–47.CrossRefGoogle Scholar
46Pack, AM, Morrell, MJ. Epilepsy and bone health in adults. Epilepsy Behav 2004; (suppl 2): S24–29.CrossRefGoogle Scholar
47Gaitatzis, A, Carroll, K, Majeed, A, Sander, JW. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 1613–22.CrossRefGoogle ScholarPubMed
48Kanner, AM, Nieto, JC. Depressive disorders in epilepsy. Neurology 1999; 53 (suppl. 2): S26–S32.Google ScholarPubMed
49Harden, CL, Goldstein, MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 2002; 16: 291–302.CrossRefGoogle Scholar